Paper
7 September 2023 Small molecules targeting ULK1 in triple-negative breast cancer treatment
Qijun Li
Author Affiliations +
Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 127891C (2023) https://doi.org/10.1117/12.2692842
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom
Abstract
With a low survival rate, triple-negative breast cancer (TNBC) is a disease difficult to treat and is mainly confined to females. Traditional therapies have bad effects on slowing down the spread of this kind of cancer, so it is essential and urgent to look for a newly developed treatment for TNBC. Defective autophagy is implicated in tumorigenesis, both as a tumor inhibitor preventing the accumulation of damaged proteins and organelles and as a cell survival mechanism that can promote the growth of established tumors. Although autophagy is carried out by the synergistic action of more than 30 proteins, only a few of them are enzymes with clear drug-targeting potential. In addition, according to past studies, the absence of ULK1 alone is sufficient to eliminate autophagy in many cell types, highlighting its particularly important role. Based on a review of the previous work, this paper focuses on ULK1-controlled autophagy as a potential method of slowing down the spread of TNBC cells or even curing cancer and describes some molecules targeting ULK1.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Qijun Li "Small molecules targeting ULK1 in triple-negative breast cancer treatment", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 127891C (7 September 2023); https://doi.org/10.1117/12.2692842
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Cancer

Breast cancer

Molecules

Tumors

Oncology

Therapeutics

Cell death

RELATED CONTENT

Emerging role of vaccines in cancer therapies
Proceedings of SPIE (January 08 2024)
eEF2K: a potential cure for cancer
Proceedings of SPIE (January 08 2024)
Regulation and therapeutic applications of autophagy in cancer
Proceedings of SPIE (September 07 2023)
The PD 1 and PD L1 checkpoint and the application...
Proceedings of SPIE (January 08 2024)

Back to Top